Background: Puumala virus infection or nephropathia epidemica (NE) is common in northern Sweden. NE causes haemorrhagic fever with renal syndrome. Most patients make a full recovery, but a convalescent phase with fatigue has been reported. Although post-infectious fatigue has been demonstrated for other viral infections, it is not well studied in relation to NE. This study assessed recovery time and levels of fatigue in former NE patients, as compared to the general population.
Background Northern Sweden has a high incidence of Puumala virus (PUUV) infection, also known as nephropathia epidemica (NE) or vole fever. The causative agent, PUUV, is a hantavirus that causes haemorrhagic fever with renal syndrome. The virus is spread by bank vole (Myodes glareolus) excreta, although the voles themselves remain unaffected by the infection. Transmission to humans is believed to occur via the inhalation of infectious aerosols; no human-to-human transmission of PUUV has been reported [1] .
Following an incubation period of 1-8 weeks (median 4) PUUV causes a sudden onset and mild form of haemorrhagic fever with renal syndrome, varying from subclinical cases to severe disease requiring haemodialysis [2] . The symptoms include high fever, malaise, headache, abdominal and back pain, dizziness, vomiting, blurred vision, thrombocytopenia, proteinuria, haematuria and transient renal failure. Case fatality is low (<0.5%) [3, 4] . No specific treatments are available, and the infection creates lifelong immunity [5] .
The Swedish Communicable Diseases Act mandates that all NE cases must be reported [6] . The diagnostic criteria constitute either a positive PUUV-RNA PCR blood test or a positive test of specific PUUV IgM and IgG antibodies, consistent with current infection. The annual incidence of NE in Sweden varies considerably, with peaks every 3-4 years related to the bank vole population cycle. Recorded incidences are on average 20/ 100,000 population per year, although the true incidence is considered to be at least eight times higher [7, 8] . During a large NE outbreak in 2007, the incidence reached 313 cases/100,000 population in the county of V€ asterbotten [3] (Figure 1 ). NE infection is considered a relatively benign disease, and its long-term consequences have been only briefly studied, with particular emphasis placed on hypertension, persisting haematuria and proteinuria and prolonged renal impairment. Initial studies indicated long-lasting health effect [9] [10] [11] , although these are not corroborated by more recent studies, with the exception of the case of persisting haematuria [12] . Most patients make a full recovery following NE infection, although a convalescent phase of several weeks with fatigue has been reported [2, 13] . Long recovery times associated with post-infectious fatigue have also been reported in other viral infections such as Epstein-Barr Virus (EBV, also called mononucleosis) [14] , Dengue fever [15] and Ross River virus [16] . Fatigue following EBV infection has been most widely investigated, in both retrospective and prospective studies [16, 17] . Post-infectious fatigue state does not exhibit specific diagnostic criteria or a commonly accepted definition, and is neither equal to chronic fatigue syndrome as defined by the Centers for Disease Control and Prevention [18] , nor the less welldefined chronic fatigue (CF).
Thus, previous research has indicated a high prevalence of post-infectious fatigue for some viral infectious diseases, but only two small studies mention fatigue in relation to NE [2, 13] . The aim of this study was to assess recovery times following NE infection and to examine levels of fatigue in former NE patients compared to the general population. 
Methods

Recruitment
We contacted all adult patients diagnosed with NE infection between 2007 and 2011 at the two laboratories serving northernmost Sweden: the Sunderby Clinical Microbiology Laboratory in Luleå and the Clinical Microbiology Laboratory at Norrlands University Hospital in Umeå. Quick-test ReaScan Puumala IgM [19] and immunofluorescence (IFA) IgM and IgG analyses [20] were used at both laboratories to diagnose NE. All IgM tests had to be confirmed by IgG seroconversion or a four-fold titer increase in paired samples, to meet the reportable criteria.
A comparison sample from the general population was obtained from Statistics Sweden, matched by age, gender and municipality of current residence of the patients. Via their Swedish personal identification numbers, any previous diagnosis of NE in the two laboratories during the last 10 years could be ruled out for the individuals in the comparison group.
The sample of NE patients and individuals for comparison received a letter of invitation, a questionnaire and a written informed consent form by postal service. All potential participants who did not respond received one reminder letter.
Questionnaire
The questionnaire consisted of three sections. Section 1 included demographic information and health-related factors. Section 2 (for patients only) included the characteristics of the NE infection, such as place of diagnosis, hospitalisation, time in bed, sick leave and time until complete recovery. In addition, patients were asked to identify which of the following symptoms dominated prior to their recovery: fatigue, pain or sleep disturbance, or any alternative symptom, which they were asked to name. Section 3 included a series of validated instruments to measure fatigue (FSS-Fatigue Severity Scale), general health (SF 36 -Short Form 36 Health Survey), sleep quality (PSQI -Pittsburgh Sleep Quality Index) and pain (BPI-SF -Brief Pain Inventory-Short Form).
In this paper, we report the findings of the fatigue assessment. The FSS is a nine-item, self-report questionnaire that assesses the effects of fatigue on daily living. The final fatigue score is measured on a scale from 1 (low fatigue) to 7 (high fatigue). The FSS has been successfully used in clinical research to distinguish the frequency and severity of fatigue between healthy subjects and patients with various infectious and noncommunicable diseases [21] .
Ethical approval
The study was approved by the Regional Ethical Review Board in Umeå, Sweden. Written informed consent was obtained from the participants.
Statistical analyses
Descriptive analyses of the study population were calculated as frequencies and percentages for categorical variables, and means and standard deviations for continuous variables, separately for the patients and the comparison group. Patients' disease-related characteristics were described, including hospitalisation, co-morbidity during the acute disease and recovery time.
The relationship between NE exposure and the fatigue score was explored via simple and multiple linear regression analyses. Multivariate models were adjusted for potential confounders such as current illness, body mass index (BMI), smoking and residence. All statistical analyses were stratified by gender, considering previous evidence of a higher frequency of post-infectious fatigue in women [15] . All analyses were performed at the 5% significance level using SPSS (v.24).
Results
Study population
In total, 1132 NE patients and 915 subjects in the comparison group returned the questionnaire, giving an overall response rate of 59.9% (65.8% among patients and 53.2% among the comparison group), making a total sample of 2047. The study population is described in Table 1 . The mean age was 60 years; no significant differences between the groups appeared regarding gender and age distribution, socioeconomic status or exercise habits. More NE patients had a current disease at the time of participation, and reported poor health to a greater extent than participants from the comparison group. There were significantly more current smokers among patients.
Disease-related characteristics of NE patients
The vast majority had received their NE infection diagnosis during the large outbreak in 2006-2007, with no difference by gender. More than 90% of the patients were bedridden during the acute NE episode, but fewer than half had to be hospitalised. More women than men were in bed or hospital, although the difference was significant only for bed confinement. Twenty-three per cent of the patients reported that they had another disease when contracting NE; significantly more women than men had some concurrent disease ( Table 2) .
Recovery time
For 32% of the patients, 6 months or longer were required for a full recovery, nearly half, 47%, experienced a recovery time of at least 3 months. In this group, the vast majority named fatigue as the main symptom preventing recovery; one-fifth of the 47% (98 individuals) spontaneously used the same, very specific Swedish word for 'feebleness' ('orkesl€ oshet') to describe the predominant symptom that prevented a complete recovery (data not shown).
Recovery time differed by gender and age. More men than women recovered within the first month, but no gender difference could be identified thereafter ( Table 2 ). Among women (but not men), young and old patients exhibited contrasting recovery times, with younger women (<60 years) tending to report longer recovery times than elderly women (60 years or older), who more often recovered within the first 3 months ( Figure 2 ).
Association between fatigue and NE infection
Among both men and women, NE patients exhibited higher FSS scores than the comparison group. One-fifth (21.6%) of the former NE patients reported high fatigue levels (score 5 or higher) whereas only 10.6% of the comparison group reported such a high score. The difference was more pronounced among women than men (Figure 3) .
A statistically significant difference in the FSS score was identified between NE patients and the comparison group among both men and women, with larger effects for women. Adjustment for current diseases, BMI, smoking habits and current residence reduced the effect only slightly ( Table 3) . Additional models adjusting for other potential confounders (age and physical activity) changed the effect estimates only marginally (data not shown).
Discussion
This study on the long-term outcomes of NE has shown that almost half of the NE patients reported a recovery time of at least 3 months. This is in line with the prospective study by Settergren et al., which reported a full recovery after 3 months for 46 out of 74 NE patients (62%). After 6 months, all 66 evaluated patients had recovered fully (6 were lost to follow up) [2] . In 1971, L€ ahdevirta reported fatigue lasting 1-5 months for 17% (6 out of 36) of NE patients evaluated [13] . To contrast that, in the present study, 6 months following the acute infection one-third of the NE patients still did not feel completely recovered. Fatigue appears to be a common problem preventing recovery. In the Dubbo prospective cohort study the prevalence of post-infectious fatigue syndrome was 27% at 3 months and 12% at 6 months following the acute episode [16] . Another prospective cohort study found a prevalence of physical fatigue in 40% of patients 6 months after acute EBV infection [17] . Previous work on EBV-associated post-infectious fatigue has demonstrated a relationship with the severity of the initial infection [16] . Such an association was not found in our data, using hospitalisation as a proxy for severity (data not shown), nor in a study of Dengue fever [15] .
The usual treatment of NE patients at the Clinic of Infectious Diseases, Umeå University Hospital in V€ asterbotten, involves signing off NE patients for up to 1 month and longer sick leave is unusual (personal communication). Our study results indicate a far longer-lasting effect on the wellbeing of a large proportion of NE patients. During major outbreak years such as 2006-2007, when the incidence rate reached 313 reported cases/100,000 inhabitants in V€ asterbotten County, and the true incidence is believed to be eight times as high, the potential public health and health economic effects can be substantial [3, 8] .
The present study was conducted in order to fill a knowledge gap regarding the association between fatigue and NE infection. The results show that NE patients displayed significantly higher FSS scores than the comparison group in both men and women. The proportion with high scores (5 or above) was twice as high in the NE patients as in the comparison group (22% versus 11%). Even when adjusting for potential confounders, this association was not altered. Moreover, the effect was stronger among women than men, with exposure to NE infection increasing the FSS score (ranging from 1 to 7) by 0.37 units in men and by 0.44 units in women, adjusted for current illness, BMI, smoking and recidence. A prospective study following acute NE infection found chronic overt hormonal deficiencies in 17% (9 out of 54) of the patients. Hormonal alterations could provide some explanation to the higher levels of fatigue; however, the hormonal changes were more common among men (22.9%) than women (12%) [22] .
In the present study, women generally displayed higher FSS scores than men in both groups. A performance test of FSS in a general Swedish setting has yet to be conducted, but other fatigue assessment tools have also indicated significantly higher fatigue scores among women than men in Sweden [23] . A Norwegian validation of FSS suggested a cut-off of 5 or higher (on the fatigue scale ranging from 1 to 7) for high fatigue and the same cut-off was used in the present study. In their sample of 1893 respondents from the general population, high fatigue scores were found in 23.1%. In our comparison group, only 10.6% reported a fatigue score of 5 or higher, whereas 21.6% of the former NE patients reported high fatigue. The Norwegian study reported that more women (26.2%) than men (19.8%) in the general population experienced high fatigue [24] . In our study, gender differences were more pronounced in the patient than the comparison group, suggesting an interaction between gender and NE exposure. In a study on Dengue fever, fatigue was significantly more common among women [15] .
Differences between men and women did not constitute the focus of our study, but became evident in the data. Gender differences in prolonged fatigue (as demonstrated for a number of viral infections) pose questions regarding potential mechanisms. For hantaviruses as a group, research has shown that even though such infections are more prevalent among males, mortality is higher in females [25] . In our study, younger women (under 60 years) were more prone to long recovery times than were older women and men. One could hypothesise that sex hormones represent a contributor to the recovery time differences seen in our data. It is likely that the pathogenesis of post-infectious fatigue is multifactorial and that the onset may be a consequence of immune alterations triggered by the viruses. However, further research is required for clarification.
Some findings from the descriptive analysis may partially explain the higher fatigue scores among former NE patients. The patient group comprised significantly more current smokers than the comparison group. This finding is to be expected, because previous studies have identified smoking as a risk factor for NE infection [26, 27] . However, adjusting for smoking in the analyses reduced the effect of NE exposure on fatigue to a negligible extent, suggesting the involvement of other pathogenic mechanisms. The patient group reported poor health and current diseases to a greater extent than the comparison group. In both groups, as expected, fatigue scores were higher among those reporting current illness, but the difference was larger in the patient group than in the comparison group; hence, NE infection appears to have an additional effect on fatigue.
This study had several limitations. The most important one is the retrospective design, prone to both recall bias and selection bias. The participation rate was low (60% in total), and was lower in the comparison group than in the patient group (53% and 66%, respectively). One reason may have been individuals' reluctance to participate where they felt high levels of fatigue, resulting in selection bias. Furthermore, a large number of patients contracted their disease during the outbreak of 2006-2007, several years before the study was conducted, and so recall bias (in particular regarding disease characteristics such as recovery time) may have affected our data. Individuals in the comparison group were checked for reported previous NE infection diagnosed in the two laboratories included in the study, but did not undergo laboratory tests to rule out any undiagnosed NE. Thus, undiagnosed infections might have been included in the comparison group, posing the potential for bias due to misclassification. Their number is however likely to be small. Finally, one major limitation is the lack of information regarding patient participants' health status or levels of fatigue prior to the NE infection.
The major strength of this study is its large study group from a well-defined geographical study area of two counties in Sweden. The involvement of a matched comparison group enabled us to compare former patients and their fatigue scores with individuals from a similar context.
The findings highlight the importance of further investigation into fatigue-affected former NE patients. A prospective study to reduce recall bias and examine the extent and properties of post-infectious fatigue following acute NE infection would thus be valuable.
Conclusions
A prolonged state of post-infectious fatigue is very common following acute NE infection. People with previous NE infection show higher fatigue scores than noninfected individuals, even 5 years after the infection. The underlying mechanisms are unclear and merit further investigation into the nature and extent of fatigue in this population.
Disclosure statement
No potential conflict of interest was reported by the authors.
Funding
V€ asterbotten County Council This study was financially supported by V€ asterbotten County Council.
